最終更新日：2025/11/25
After promising results in the trial, the oncology team decided to include lexatumumab in the combination therapy regimen.
正解を見る
After promising results in the trial, the oncology team decided to include lexatumumab in the combination therapy regimen.
音声機能が動作しない場合はこちらをご確認ください
編集履歴（0）
